Serpin E2 has emerged as a marker of tumor prognosis, and increasing numbers of studies have investigated the mechanisms by which serpin E2 mediates tumor metastasis and its therapeutic targets (Bergeron et al., 2010), which has profound significance for the recovery of patients, prevention and treatment of tumor recurrence, and improvement of patient survival (Table 2). Here, SERPINE2 is linked to neoplasm.